Find the latest and updated news related to DSSTox_CID_3333 aggregated by PharmaCompass.com.

DSSTox_CID_3333
News
Full Screen View

DSSTox_CID_3333

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

70 Suppliers, 32 USDMF, 25 CEP/COS, 9 JDMF, 8 EU WC, 7 KDMF, 28 NDC API, 41 Listed Suppliers

DEVELOPMENTS

48 Drug(s) in Development

48 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

282 Dossiers, 37 FDA Orange Book, 119 Europe, 17 Canada, 59 Australia, 25 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITION

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

Suppliers, 10 Kerry, 9 Roquette, 8 Sigachi Industries, 7 Gangwal Chemicals, 6 Actylis, 6 Microlex e.U, 6 Seppic, 5 Gangwal Healthcare, 4 BASF, 4 Nanjing Well Pharmaceutical, 3 DFE Pharma, 2 Finar, 1 The Dow Chemical Company, 1 Ideal Cures Pvt Ltd, 1 Pharmatrans-Sanaq, 1 Jai Radhe Sales, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Nanjing Bold Chemical, 1 Vasa Pharmachem, 1 Rochem International Inc, 1 Kima Chemical, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Prachin Chemical, 1 SPI Pharma

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 19 Solubilizers, 14 Thickeners and Stabilizers, 14 Direct Compression, 10 Parenteral, 8 Coating Systems & Additives, 8 Co-Processed Excipients, 8 Film Formers & Plasticizers, 7 Disintegrants & Superdisintegrants, 7 Granulation, 6 Topical, 5 Controlled & Modified Release, 4 Rheology Modifiers, 4 Emulsifying Agents, 3 Lubricants & Glidants, 3 Taste Masking, 2 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

35 US Medicaid Prescriptions, 98 Finished Drug Prices

MARKET PLACE

13 APIs, 4 DOSSIERS // FDF

PATENTS

27 US Patents, 1 US Exclusivities, 15 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

48 News

48 News

News

Apotex`s Generic Mometasone Furoate Receives Approval in the U.S.

POST ENQUIRY

Find the latest and updated news related to DSSTox_CID_3333 aggregated by PharmaCompass.com.

DSSTox_CID_3333 News Full Screen View

DSSTox_CID_3333

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

70 Suppliers

32 USDMF

25 CEP/COS

9 JDMF

8 EU WC

7 KDMF

28 NDC API

41 Listed Suppliers

DEVELOPMENTS

48 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

282 Dossiers

37 FDA Orange Book

119 Europe

17 Canada

59 Australia

25 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITION

OINTMENT;TOPICAL - 0.1%

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.05MG/INH

AEROSOL, METERED;INHALATION - 0.10MG/INH

AEROSOL, METERED;INHALATION - 0.20MG/INH

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INHALATION - 0.11MG/INH

POWDER;INHALATION - 0.22MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

Suppliers

10 Kerry

9 Roquette

8 Sigachi Industries

7 Gangwal Chemicals

6 Actylis

6 Microlex e.U

6 Seppic

5 Gangwal Healthcare

4 BASF

4 Nanjing Well Pharmaceutical

3 DFE Pharma

2 Finar

1 The Dow Chemical Company

1 Ideal Cures Pvt Ltd

1 Pharmatrans-Sanaq

1 Jai Radhe Sales

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Nanjing Bold Chemical

1 Vasa Pharmachem

1 Rochem International Inc

1 Kima Chemical

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Prachin Chemical

1 SPI Pharma

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders

19 Solubilizers

14 Thickeners and Stabilizers

14 Direct Compression

10 Parenteral

8 Coating Systems & Additives

8 Co-Processed Excipients

8 Film Formers & Plasticizers

DSSTox_CID_3333
News
Full Screen View

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons